Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 23Recruiting 8Unknown 4Terminated 4Withdrawn 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 2Polycystic Ovary Syndrome 1Insulin Resistance 1Breast Neoplasms 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × High-Intensity Interval Training × Clear all
NCT06190600 2025-04-30

SPORTNATHy

The Greater Poland Cancer Centre

Phase NA Active not recruiting
40 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT02303470 2024-06-20

PCOS & Insulin Resistance Exercise Study

University of California, San Francisco

Phase NA Active not recruiting
47 enrolled

Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡